230 results on '"Pomerantz, Roger J."'
Search Results
2. HIV-1-Mediated Apoptosis of Neuronal Cells: Proximal Molecular Mechanisms of HIV-1-Induced Encephalopathy
3. Reply to Lagier et al
4. Approaching Eradication of Highly Active Antiretroviral Therapy-Persistent Human Immunodeficiency Virus Type 1 Reservoirs with Immune Activation Therapy
5. Reservoirs of Human Immunodeficiency Virus Type 1: The Main Obstacles to Viral Eradication
6. Recombinant Rabies Virus as Potential Live-Viral Vaccines for HIV-1
7. Amphipathic Domains in the C Terminus of the Transmembrane Protein (gp41) Permeabilize HIV-1 Virions: A Molecular Mechanism Underlying Natural Endogenous Reverse Transcription
8. A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection
9. The Challenge of Finding a Cure for HIV Infection
10. Highly Attenuated Rabies Virus Based Vaccine Vectors Expressing Simian-Human Immunodeficiency $Virus_{89.6P}$ , Env and Simian Immunodeficiency $Virus_{mac239}$ Gag Are Safe in Rhesus Macaques and Protect from an AIDS-like Disease
11. Attenuation of HIV-1 Infection by Other Microbial Agents
12. HIV-1 Infection and Genomics: Sorting out the Complexity
13. Intensification and Stimulation Therapy for Human Immunodeficiency Virus Type 1 Reservoirs in Infected Persons Receiving Virally Suppressive Highly Active Antiretroviral Therapy
14. Gene Therapy Using a Simian Virus 40-Derived Vector Inhibits the Development of in vivo Human Immunodeficiency Virus Type 1 Infection of Severe Combined Immunodeficiency Mice Implanted with Human Fetal Thymic and Liver Tissue
15. Human Immunodeficiency Virus Type 1-Infected Persons with Residual Disease and Virus Reservoirs on Suppressive Highly Active Antiretroviral Therapy Can Be Stratified into Relevant Virologic and Immunologic Subgroups
16. Reduced Mobilization of CD34⁺ Stem Cells in Advanced Human Immunodeficiency Virus Type 1 Disease
17. Potent Inhibition of Human Immunodeficiency Virus Type 1 Replication by an Intracellular Anti-Rev Single-Chain Antibody
18. CD14 is Involved in Control of Human Immunodeficiency Virus Type 1 Expression in Latently Infected Cells by Lipopolysaccharide
19. Blocked Early-Stage Latency in the Peripheral Blood Cells of Certain Individuals Infected with Human Immunodeficiency Virus Type 1
20. Chemokine Receptors and the Molecular Basis for Human Immunodeficiency Virus Type 1 Entry into Peripheral Hematopoietic Stem Cells and Their Progeny
21. Isolation of a Second Recombinant Human Respiratory Syncytial Virus Monoclonal Antibody Fragment (Fab RSVF2-5) That Exhibits Therapeutic Efficacy in vivo
22. Human Herpesvirus 8 DNA Sequences in CD8⁺ T Cells [with Reply]
23. Human Herpesvirus Type 8 DNA Sequences in Cell-Free Plasma and Mononuclear Cells of Kaposi's Sarcoma Patients
24. Increased Human Immunodeficiency Virus Type 1 Replication in Human Peripheral Blood Mononuclear Cells Induced by Ethanol: Potential Immunopathogenic Mechanisms
25. Exogenous IL-7 induces Fas-mediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infection
26. Daily low-dose subcutaneous interleukin-2 added to single- or dual- nucleoside therapy in HIV infection does not protect against CD4 (super +) T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial
27. Lentiviral expression of HIV-1 Vpr induces apoptosis in human neurons
28. Treatment of Mycobacterium avium complex immune reconstitution disease in HIV-1-infected individuals
29. Twenty years of therapy for HIV-1 infection
30. Identification of an RNA element that confers post-transcriptional repression of connective tissue growth factor/hypertrophic chondrocyte specific 24 (ctgf/hcs24) gene: Similarities to retroviral RNA-protein interactions
31. Nuclear and nucleolar targeting of human ribosomal protein S25: Common features shared with HIV-1 regulatory proteins
32. Association of provider and patient characteristics with HIV-infected women's antiretroviral therapy regimen
33. A cis-acting peptide signal in human immunodeficiency virus type I Rev which inhibits nuclear entry of small proteins
34. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy
35. Kynurenine pathway metabolism in human blood–brain–barrier cells: implications for immune tolerance & neurotoxicity
36. Effects of Highly Active Antiretroviral Therapy on HIV-1-Associated Oral Complications
37. T-Cells and Excitotoxicity: HIV-1 and Other Neurodegenerative Disorders
38. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART
39. HIV-1 Vif versus APOBEC3G: newly appreciated warriors in the ancient battle between virus and host
40. HIV: Cross-talk and viral reservoirs
41. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
42. The Expert Speaks: Immune Reconstitution Syndrome in AIDS
43. Recombinant Rhabdoviruses as Potential Vaccines for HIV-1 and Other Diseases
44. HIV: A tough viral nut to crack
45. Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction
46. Genotypic alteration of HAART-persistent HIV-1 reservoirs in vivo
47. Cell-type-specific gene delivery into neuronal cells in vitro and in vivo
48. Binding of ALX40-4C to APJ, a CNS-based receptor, inhibits its utilization as a co-receptor by HIV-1
49. Cell–cell fusion and internalization of the CNS-based, HIV-1 co-receptor, APJ
50. SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.